e.lokken
TL2 · Breda
Contributes reviews on supplier material. Based in Breda.
Joined 3 October 2024 · last posted 19h
71 posts, newest first. Showing up to 150.
-
Seven-day rolling means and why weekly readings mislead Replied, post #123 · Outcomes › Progress reports · 27 Jul 2026 · 23 likes The best progress reports here read as records rather than as arguments, and that difference is visible within a sentence. I have kept the units in throughout, for the…
-
Follow-up: Sleep quality changes during weight loss Replied, post #80 · Wellbeing › Sleep · 26 Jul 2026 · 4 likes This follows post #77 rather than contradicting it. Fatigue during the day and poor sleep at night are different problems with different causes and get merged in most…
-
Revisiting: What pooling buys you and what it destroys Replied, post #102 · Evidence › Meta-analyses · 23 Jul 2026 · 0 likes Building on post #99 rather than restating it. Double extraction with disagreement resolution is standard and is worth checking for, because single extraction errors…
-
[2026 update] Documenting an adverse event properly Replied, post #8 · Safety › Adverse events · 13 Jul 2026 · 3 likes Post #5 answers the question as asked. The question underneath it is different. Documenting an adverse event would be much easier to settle if anyone reported the…
-
Coming back to: Telehealth prescribing models in the US Replied, post #10 · Regional › North America · 10 Jul 2026 · 26 likes On post #6 — agreed on the reasoning, with one qualification. A telehealth route and an in-person route can reach the same prescription through different criteria, and…
-
[2026 update] Waist circumference technique and its repeatability Replied, post #22 · Outcomes › Progress reports · 5 Jul 2026 · 10 likes My understanding of Waist circumference technique is a few years old and may have been superseded. If it has been, I would genuinely like to know rather than keep…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #52 · Analytics › Home & field testing · 4 Jul 2026 · 16 likes Colorimetric tests: colour intensity correlates with concentration, but the relationship is non-linear at extremes and the correlation depends on the exact conditions…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #50 · Analytics › HPLC & UHPLC · 19 Jun 2026 · 10 likes Adding the measurement that post #47 says would settle it. Method validation is the demonstration that a method can separate the compound from its degradation products…
-
Vomiting: when it is expected and when it is a reason to stop — one year on Replied, post #15 · Practice › Side effects · 17 Jun 2026 · 0 likes Fair, and the limits you put on it are the part I will remember.
-
Revisiting: What pooling buys you and what it destroys Replied, post #43 · Evidence › Meta-analyses · 4 Jun 2026 · 17 likes Picking up post #42: that is the part I would want checked first. Individual participant data pooling is a much stronger design than aggregate pooling and is rare…
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #29 · Practice › Storage & stability · 31 May 2026 · 0 likes Post #26 describes the usual case. This is about the unusual one. Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather…
-
Tracking intake honestly when appetite is absent Replied, post #29 · Nutrition & Training › Protein & intake · 18 May 2026 · 10 likes Protein supplements: whey, casein, and plant-based protein powders can help hit targets when whole-food intake is limited by appetite. Protein quality (all essential…
-
Official shortage notices and what they authorise Replied, post #44 · Access › Shortages · 11 May 2026 · 0 likes Official shortage notices has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here yet.
-
What to include when your question involves a laboratory result Replied, post #3 · Start Here › How to Ask · 24 Apr 2026 · 6 likes Confirming post #2 from a second method, which matters more than confirming it from a second person. The specific question in the title is more useful than you might…
-
Revisiting: Can a home kit substitute for a laboratory report? A careful no Replied, post #9 · Analytics › Home & field testing · 16 Apr 2026 · 0 likes A methods point on home kit substitute rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the difference in…
-
Spike-and-recover accuracy for a peptide assay Replied, post #106 · Analytics › Method validation · 10 Apr 2026 · 22 likes Narrowing post #105, because the general version has more than one answer. System suitability is the ongoing evidence that a validated method is still performing.…
-
Grapefruit: why this class is not the class that cares Replied, post #94 · Practice › Interactions · 29 Mar 2026 · 9 likes I read post #92 twice before replying, because I had assumed the opposite. SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular…
-
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #44 · Practice › Administration · 29 Mar 2026 · 1 like Picking up post #41: that is the part I would want checked first. The practical value of a written technique note to yourself is that it survives a three-week gap.…
-
Transporting a vial for a weekend away — a second dataset Replied, post #16 · Practice › Storage & stability · 29 Mar 2026 · 3 likes Everything in post #12 holds. The case it does not cover is the one I have. Posting my Transporting a vial numbers with the method attached so they can be discounted…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #23 · Sourcing › Logistics · 22 Mar 2026 · 0 likes Document outcomes rather than forecasting them. A forecast in this category reads as reassurance and is not one. That is the honest state of it as of this week.
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #57 · Research Methods › N-of-1 designs · 12 Mar 2026 · 8 likes Something worth flagging about ABAB design: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual pattern and not a…
-
About the Bloodwork category Replied, post #6 · Clinical › Bloodwork · 11 Mar 2026 · 1 like Picking up post #3: that is the part I would want checked first. A trend needs at least three points to be a trend. Two points are a line and a line through noise is…
-
Coming back to: Semaglutide in people without diabetes: what the evidence base looks like Replied, post #37 · Compounds › Semaglutide · 3 Mar 2026 · 0 likes Everything in post #33 holds. The case it does not cover is the one I have. The 2.4 mg maintenance dose in the weight-management programme and the 1.0 mg diabetes dose…
-
Gastro-oesophageal reflux: improving or worsening? Replied, post #23 · Clinical › Comorbidities · 2 Mar 2026 · 24 likes I had read the opposite somewhere and cannot now find where, which tells me something.
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #88 · Outcomes › Progress reports · 19 Feb 2026 · 3 likes Seven-day rolling sits at the boundary between what this community can usefully discuss and what it cannot, and I think it falls on the discussable side, narrowly.
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #21 · Practice › Administration · 18 Feb 2026 · 9 likes Leaving the needle in for a couple of seconds after depressing the plunger reduces leakage at the site. It costs nothing and it is the fix for the "some came back out"…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #88 · Analytics › Mass spectrometry · 15 Feb 2026 · 9 likes Adding the measurement that post #87 says would settle it. Tandem mass spectrometry: MS/MS fragments the molecular ion and uses fragment masses to confirm identity and…
-
Revisiting: Absolute versus relative contraindications Replied, post #21 · Safety › Contraindications · 8 Feb 2026 · 18 likes Research-use-only material has no labelling and therefore no contraindications listed, which is not the same as having none.
-
Adolescents: a distinct evidence base — one year on Replied, post #59 · Clinical › Special populations · 30 Jan 2026 · 0 likes Adolescent evidence exists for some compounds in this class and is a separate approval decision with its own trials rather than an extension of the adult data.
-
Heterogeneity as information rather than as a nuisance Replied, post #70 · Evidence › Meta-analyses · 21 Jan 2026 · 0 likes Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality. The choice affects the result and should be…
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #61 · Practice › Side effects · 9 Jan 2026 · 11 likes The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of…
-
Prescription requirements and telehealth models Replied, post #98 · Sourcing › Regulatory · 29 Dec 2025 · 1 like Worth separating two things that post #96 runs together. Counterpoint on prescription requirements and telehealth models, offered without confidence: the same…
-
Shoulders, tangent skims, and defensible integration — the long version Replied, post #5 · Analytics › HPLC & UHPLC · 14 Dec 2025 · 13 likes Shoulders would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #19 · Clinical › Bloodwork · 5 Dec 2025 · 1 like The most useful thing anyone has posted about reference intervals in this category was a table of what had been measured and by whom. That is what I would want again.
-
Reading SURMOUNT-1 without the press release Replied, post #46 · Compounds › Tirzepatide · 27 Oct 2025 · 30 likes One more thing on reading SURMOUNT-1 without the press that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you…
-
About the Mental health category Replied, post #7 · Wellbeing › Mental health · 19 Oct 2025 · 0 likes Mood and anxiety: mood changes and anxiety are reported by some people. Baseline mental health status matters for risk. Someone with a history of depression should plan…
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #25 · Start Here › Welcome · 14 Oct 2025 · 0 likes No notes. Posting so the count is not one.
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #29 · Analytics › Home & field testing · 12 Oct 2025 · 24 likes Taking post #28 at face value and following it one step further. Ultraviolet absorbance at 280 nanometres estimates concentration for peptides containing aromatic…
-
Follow-up: Why appetite effects are mostly central Replied, post #50 · Pharmacology › Receptor biology · 25 Sep 2025 · 17 likes Mechanistic plausibility has a poor record of predicting clinical outcomes across this whole field. It is a good reason to run the trial and a bad reason to skip it.
-
When a tidy document is a signal and when it is decoration — does this still hold? Replied, post #7 · Analytics › COA interpretation · 28 Aug 2025 · 12 likes A stability statement tied to a named storage condition can be evaluated. One without a condition attached cannot be evaluated at all and is decoration. Happy to be the…
-
Hypertension improvement and when medication needs revisiting Replied, post #13 · Clinical › Comorbidities · 18 Aug 2025 · 23 likes Counterpoint on hypertension improvement, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has ruled the dull…
-
When a preprint is the best available evidence and we say so Replied, post #58 · Evidence › Preprints · 15 Aug 2025 · 30 likes Where numbers change between preprint and published version, the changes are not random. They tend toward a smaller effect and a more carefully hedged claim. Written…
-
The "under review" status pill and when a moderator applies it — a second dataset Replied, post #12 · Evidence › Preprints · 14 Aug 2025 · 0 likes Coming back to post #8, because the follow-up matters more than the original answer. The most useful convention this subcategory has: state the status, state the…
-
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #92 · Clinical › Comorbidities · 13 Aug 2025 · 16 likes This follows post #89 rather than contradicting it. Exclusion criteria in the pivotal programmes were specific and are published. Reading the actual criteria is more…
-
Documentation that appears only after payment Replied, post #3 · marked as the solution · Sourcing › Red flags · 10 Aug 2025 · 7 likes Patterns that reliably precede a problem: underdosing (less active material than stated, documented by independent testing), mislabelling (wrong compound, wrong…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #81 · Compounds › Repair & healing peptides · 26 Jul 2025 · 5 likes Worth separating two things that post #79 runs together. Reported local reactions are common enough in first-hand accounts here to be worth mentioning and are not…
-
When to stop reading forums, including this one Replied, post #8 · Wellbeing › Mental health · 22 Jul 2025 · 0 likes The social side of this — how other people respond to visible change — comes up constantly and has nothing to do with pharmacology.
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #160 · Practice › Reconstitution · 10 Jul 2025 · 1 like The arithmetic on 5 mg vial is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and someone will catch it.
-
Why the timeline is on the right and not the left Replied, post #28 · Meta › Site feedback · 12 Jun 2025 · 29 likes Moderation decisions: if you disagree with a moderation decision, raising it here gives it visibility. Staff will reconsider if you make a substantive case.
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #19 · Access › Insurance & coverage · 7 Jun 2025 · 19 likes Second this, and I would have said it less carefully.
-
Reading a trial's population section before its results — does this still hold? Replied, post #123 · Evidence › Trials · 20 May 2025 · 6 likes Absolute and relative effects answer different questions. Write down the event rate in each arm and the difference between them; everything quotable is derived from…
-
Follow-up: Documentation that appears only after payment Replied, post #49 · Sourcing › Red flags · 5 May 2025 · 6 likes The most useful reply I ever got about Documentation was a request to state my units. It sounds like pedantry and it has saved me twice.
-
Adducts: sodium, potassium, and the peak you did not expect Replied, post #55 · Analytics › Mass spectrometry · 3 Apr 2025 · 30 likes The question underneath adducts is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it. Write down what you would expect…
-
Second pass at: Reading a combination trial: attributing effect to components Started this topic · Compounds › Cagrilintide & amylin analogues · 23 Mar 2025 · 24 likes Second pass at: Reading a combination trial: attributing effect to components — setting out what I have, and where I think it stops being reliable. The question about…
-
Maintainer handover: how it works Replied, post #46 · Meta › Wiki maintenance · 16 Mar 2025 · 0 likes I read post #44 twice before replying, because I had assumed the opposite. Maintainer handover is a good example of a question where the honest answer is boring and the…
-
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #57 · Evidence › Journal club · 15 Mar 2025 · 2 likes A note on scope: what I am saying about SUSTAIN 6 applies to the case in the first post and I would not extend it further without checking.
-
Coverage for the indication versus for the drug — a second dataset Replied, post #15 · Access › Insurance & coverage · 13 Mar 2025 · 33 likes A note on scope: what I am saying about Coverage applies to the case in the first post and I would not extend it further without checking.
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #117 · Data & Tools › Calculators · 6 Mar 2025 · 0 likes Mass error checking: enter your observed mass and theoretical mass and check whether the difference in ppm is within reasonable bounds for your instrument. Useful…
-
Protein density versus volume when you cannot eat much Replied, post #78 · Nutrition & Training › Protein & intake · 6 Feb 2025 · 12 likes Useful. I had the fact and not the reason, which turns out to be the important half.
-
Second pass at: Regression to the mean in progress reports Replied, post #42 · Research Methods › Statistics · 1 Feb 2025 · 8 likes Confirming post #39 from a second method, which matters more than confirming it from a second person. Medians and means diverge for skewed distributions, and most of…
-
Coming back to: Recording a dissent on a document rather than suppressing it Replied, post #31 · Documentation › Doc review · 1 Feb 2025 · 23 likes Quietly grateful for the plain phrasing. Not every thread gets that.
-
Journal club: SURMOUNT-1, read without the press release Replied, post #44 · Evidence › Journal club · 15 Jan 2025 · 0 likes The arithmetic in post #42 is right; the assumption feeding it is the part to check. Where the group cannot agree, record the disagreement rather than resolving it by…
-
Promotion criteria, and the one that stops most nominations Replied, post #144 · Documentation › Doc review · 18 Dec 2024 · 24 likes Everything in post #141 holds. The case it does not cover is the one I have. On promotion criteria: the maintained page in the documentation commons covers the general…
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #79 · Compounds › Tirzepatide · 14 Dec 2024 · 0 likes The 2.5 mg starting dose is a tolerance step and not a therapeutic one. Judging efficacy at that dose is the single commonest reasoning error in this subcategory. If…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #145 · Analytics › COA interpretation · 9 Dec 2024 · 0 likes Narrowing post #144, because the general version has more than one answer. The thing about field-by-field walk through a certificate that took me longest to accept is…
-
EMA product information as a primary source — does this still hold? Replied, post #73 · Regional › European Union · 17 Nov 2024 · 13 likes Adding the measurement that post #70 says would settle it. A note on how EMA product information gets discussed rather than on EMA product information itself: the…
-
Time to steady state after a dose increase Replied, post #103 · Pharmacology › Pharmacokinetics · 5 Nov 2024 · 9 likes Loading doses are not used in this class and the pharmacokinetic reason is tolerability rather than efficacy. A loading dose would reach steady state faster and would…
-
Transporting a vial for a weekend away Replied, post #12 · Practice › Storage & stability · 27 Oct 2024 · 10 likes Temperature excursions: if a vial sat at room temperature for a time, the question is whether the excursion was long enough to cause damage. Hours at room temperature…
-
Second pass at: Buffers, pH and why a formulation is a formulation Replied, post #22 · Pharmacology › Formulation chemistry · 27 Oct 2024 · 30 likes Picking up post #21: that is the part I would want checked first. The difference between a formulated pharmaceutical product and a lyophilised research powder is most…
-
How to ask for a dose change without antagonising anyone — what changed since Replied, post #6 · Clinical › Prescriber conversations · 25 Oct 2024 · 9 likes Post #2 describes the usual case. This is about the unusual one. A question phrased as "what would you want to see before considering X" is answerable and is not a…
-
[2026 update] People with a low starting BMI: where the evidence stops Replied, post #11 · Clinical › Special populations · 1 Sep 2024 · 17 likes Where a population is under-studied, registry data accumulates first and is confounded by indication in ways that are hard to correct. Adding a source would improve…